**Core Concept:** **Persistent Pulmonary Hypertension of Neonate (PPHN)** is a serious condition in newborns characterized by high blood pressure in the lungs, leading to impaired oxygenation and respiratory distress. **Shunt from right to left** across patent ductus arteriosus (PDA) is a compensatory mechanism in PPHN, but it can cause systemic hypoxia if left untreated.

**Why the Correct Answer is Right:** **Inhaled Nitric Oxide (iNO)** is a selective pulmonary vasodilator that helps to reduce pulmonary vascular resistance and improve oxygenation in PPHN. It works by inhibiting the binding of oxygen to haemoglobin in the pulmonary circulation, reducing the shunting of blood from right to left across the ductus arteriosus.

**Why Each Wrong Option is Incorrect:**

A. **Inhaled Oxygen (O2)** is essential for oxygenation, but it does not address the underlying pulmonary hypertension in PPHN.

B. **Inhaled Bronchodilators (e.g., Epinephrine)** primarily relax smooth muscle in the airways and are not effective in treating PPHN.

C. **Inhaled Nitric Oxide (iNO)** is sometimes used for its vasodilatory properties, but **Inhaled Nitric Monoxide (iNO2)** is not a recognized drug for treating PPHN.

D. **Oxygen Cannulation (O2 Canula)** improves oxygen saturation but does not target the pulmonary hypertension in PPHN.

**Clinical Pearl:** **Inhaled Nitric Oxide (iNO)** is a selective pulmonary vasodilator primarily used in neonatal intensive care units to treat PPHN. It is typically administered in combination with other supportive care measures.

**Correct Answer:**

Correct Answer: **Inhaled Nitric Oxide (iNO)** (Option D)

---

**Core Concept:** Patent Ductus Arteriosus (PDA) is a persistent fetal blood vessel that connects the aorta and pulmonary artery, allowing oxygenated blood to bypass the lungs and return directly to the systemic circulation. In premature infants or those with respiratory distress, the PDA can lead to high pulmonary blood flow, shunting, and decreased systemic blood flow.

**Why the Correct Answer is Right:** Inhaled Nitric Oxide (iNO) is a selective pulmonary vasodilator, which means it narrows the blood vessels in the lungs by releasing nitric oxide, a gas that binds to guanylate cyclase, leading to increased cyclic guanosine monophosphate (cGMP) production and relaxation of pulmonary arterial smooth muscle. This results in a decrease in pulmonary vascular resistance, allowing oxygenation to improve and relieve respiratory distress.

**Why Each Wrong Option is Incorrect:**

A. Inhaled Oxygen (O2) increases oxygen saturation but does not directly address the pulmonary hypertension that is the primary issue in PPHN.

B. Inhaled Epinephrine (Epinephrine) is a catecholamine that stimulates beta-